CSXCX
Price
$46.33
Change
-$1.50 (-3.14%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

CSXCX vs VFINX

Header iconCSXCX vs VFINX Comparison
Open Charts CSXCX vs VFINXBanner chart's image
Calvert US Large Cap Core Rspnb Idx C
Price$46.33
Change-$1.50 (-3.14%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
CSXCX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSXCX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSXCX is a StrongBuy and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. CSXCX (5.92B). VFINX pays higher dividends than CSXCX: VFINX (1.24) vs CSXCX (0.17). CSXCX was incepted earlier than VFINX: CSXCX (24 years) vs VFINX (48 years). CSXCX is a more actively managed with annual turnover of: 8.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than CSXCX: VFINX (0) vs CSXCX (5000). VFINX (27.63) and CSXCX (26.62) have marching annual gain over last year. CSXCX (91.69) and VFINX (88.65) have equivalent 5 years return.
CSXCXVFINXCSXCX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years48 years-
Gain YTD25.72227.27594%
Front LoadN/AN/A-
Min. Initial Investment50000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.92B1.37T0%
Annual Yield % from dividends0.171.2413%
Returns for 1 year26.6227.6396%
Returns for 3 years26.6630.9986%
Returns for 5 years91.6988.65103%
Returns for 10 years171.49193.6289%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc